Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Amgen
Ownership Structure: publicly traded (ticker symbol AMGN)
Headquartered in: California
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $931,844,837
Number of records: 22
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| healthcare-related offenses | $833,000,000 | 3 |
| government-contracting-related offenses | $76,464,000 | 9 |
| competition-related offenses | $19,230,768 | 2 |
| employment-related offenses | $3,073,701 | 3 |
| environment-related offenses | $70,968 | 4 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| off-label or unapproved promotion of medical products | $833,000,000 | 3 |
| False Claims Act and related | $76,464,000 | 9 |
| price-fixing or anti-competitive practices | $19,230,768 | 2 |
| benefit plan administrator violation | $2,750,000 | 1 |
| employment discrimination | $283,701 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year  | Agency | Penalty Amount |
| Amgen Inc. | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
| Amgen, Inc. | employment discrimination | 2018 | OFCCP | $283,701 |
| Amgen, Inc. | benefit plan administrator violation | 2017 | private lawsuit-federal | $2,750,000 |
| Amgen Inc. | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | $71,000,000 |
| Amgen Inc. | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
| Amgen, Inc. | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
| AMGEN SF, LLC | workplace safety or health violation | 2013 | OSHA | $5,400 |
| Amgen Inc. | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Amgen Inc. | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
| Amgen, Inc. | labor relations violation | 2011 | NLRB | $40,000 |
| Amgen Inc. | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Immunex Corporation | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
| Amgen Inc. | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
| Amgen, Inc. | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Amgen, Inc. | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
| Immunex Corp. | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Amgen and Immunex | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
| Amgen Inc. | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
| Amgen Inc. | environmental violation | 2007 | EPA | $24,368 |
| AMGEN INC | environmental violation | 2006 | MA-ENV | $11,600 |
| Amgen Manufacturing, Limited | environmental violation | 2006 | EPA | $20,000 |
| AMGEN INC | environmental violation | 2002 | MA-ENV | $15,000 |
